on examination 1-3 days after return to sea level and compared with control rats , they exhibited pulmonary hypertension , reduced angiotensin-converting enzyme activity , greater vascular responsiveness to angiotensin ii ( aii ) , and resistance to blockade of aii pulmonary pressor responses by the aii antagonist , saralasin .
C0003009
aii
C0036193
saralasin